Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
03/29/2011 | US7914818 Prevent drug abruse; side effect reduction; administering mixture of opioid antagonist, releasable form and sequestering agent |
03/29/2011 | US7914817 Treatment of inflammatory bowel disease |
03/29/2011 | US7914802 Mucosal vaccine adjuvants containing bacterial flagellins as an active component |
03/29/2011 | US7914801 Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations |
03/29/2011 | US7914799 Anti-fungal composition |
03/29/2011 | US7914791 Vaccine |
03/29/2011 | US7914537 Devices and methods for the restoration of a spinal disc |
03/29/2011 | CA2448083C Liquid preparations of fudosteine |
03/29/2011 | CA2443672C Aryl and biaryl piperidines used as mch antagonists |
03/29/2011 | CA2436764C Rehydration composition |
03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
03/29/2011 | CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder |
03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
03/29/2011 | CA2379508C Biphasic skin composition comprising ascorbic acid, ceramides and betaglycane |
03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
03/29/2011 | CA2323058C Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression |
03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
03/24/2011 | WO2011034210A1 Pharmaceutical combination for treating tumor |
03/24/2011 | WO2011033884A1 Prophylactic agent for muscular contracture |
03/24/2011 | WO2011032984A1 Lubiprostone for obstetrical or gynecological applications |
03/24/2011 | WO2011032912A1 Pharmaceutical composition having the active substances metformin and sitagliptin or vildaliptin |
03/24/2011 | WO2009158499A3 Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems |
03/24/2011 | WO2009143174A3 Chemical permeation enhancers enhance nerve blockade by toxins |
03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
03/24/2011 | US20110071168 Nitric oxide donors for inducing neurogenesis |
03/24/2011 | US20110071111 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
03/24/2011 | US20110071102 Compositions and Methods to Treat Recurrent Medical Conditions |
03/24/2011 | US20110071081 Methods useful in the treatment of bone resorption diseases |
03/24/2011 | US20110071078 Methods for treating neurological deficits |
03/24/2011 | US20110070316 Antimicrobial Compositions Containing Synergistic Combinations of Quaternary Ammonium Compounds and Essential Oils and/or Constituents Thereof |
03/24/2011 | US20110070306 Antimicrobial nanoemulsion compositions and methods |
03/24/2011 | US20110070289 Adaptable modified virus vector to deliver modified messenger ribonucleic acid as a medical treatment device to manage diabetes mellitus and other protein deficient diseases |
03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
03/24/2011 | CA2774149A1 Lubiprostone for obstetrical or gynecological applications |
03/24/2011 | CA2774118A1 Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptin |
03/24/2011 | CA2772314A1 Pharmaceutical combination for treating tumor |
03/23/2011 | EP2298812A2 Remedies for juvenile chronic arthritis and related diseases |
03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
03/23/2011 | EP2298790A1 Daptomycin analogs as antibacterial agents |
03/23/2011 | EP2298761A1 HIV inhibiting pyrimidines derivatives |
03/23/2011 | EP2298359A1 Nucleic acid capable of controlling degranulation of mast cell |
03/23/2011 | EP2298350A2 Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders |
03/23/2011 | EP2298349A1 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia |
03/23/2011 | EP2298346A2 Human antibodies specific to kdr and uses thereof |
03/23/2011 | EP2298334A2 Tweak receptor |
03/23/2011 | EP2298333A2 Tweak receptor |
03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
03/23/2011 | EP2298306A1 A method of analgesia |
03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
03/23/2011 | EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
03/23/2011 | EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
03/23/2011 | EP2298297A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme |
03/23/2011 | EP2298282A1 Combination of drugs having different physical properties into single dosage form |
03/23/2011 | EP2298280A2 Gel comprising a combination of flurbiprofen and muscle relaxant |
03/23/2011 | EP2297183A1 Treatment for diseases relying on discovery that thioredoxin mediates nitric oxide release in cells |
03/23/2011 | EP2296670A1 Glycosaminoglycan oral use and compositions |
03/23/2011 | EP2296661A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment |
03/23/2011 | EP2296645A2 Combination antitumor therapy |
03/23/2011 | EP2296642A1 Compositions comprising amino acids, with pro-angiogenic activity |
03/23/2011 | EP2296640A1 Methods for preventing the development of retinopathy by the oral administration of nnr ligands |
03/23/2011 | EP2296633A2 The use of solid carrier particles to improve the processability of a pharmaceutical agent |
03/23/2011 | EP2296470A2 Compositions and methods for inhibiting gastric acid secretion |
03/23/2011 | EP2023918B1 Cyclosporins for the treatment and prevention of ocular disorders |
03/23/2011 | EP1772145B1 Method of effectively using medicine and method concerning prevention of side effect |
03/23/2011 | EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
03/23/2011 | EP1469878B1 Fgfr agonists |
03/23/2011 | EP1448205B1 Combinations for the treatment of immunoinflammatory disorders |
03/23/2011 | EP1351707B1 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
03/23/2011 | EP1320386B1 A novel cationic lipopolymer as biocompatible gene delivery agent |
03/23/2011 | EP1320377B1 Hla binding peptides and their uses |
03/23/2011 | CN1981031B Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses |
03/23/2011 | CN101990450A Use of lipid-rich nutrition for the treatment of post-operative ileus |
03/23/2011 | CN101990432A Bitherapy and tritherapy used for treating an hiv-positive patient |
03/23/2011 | CN101987200A Compound medicine containing antihypertensive peptide and aldosterone receptor antagonist for curing hypertension |
03/23/2011 | CN101987199A Antipyretic and analgesic injection composition |
03/23/2011 | CN101987198A Medicinal composition |
03/23/2011 | CN101987197A Method and reagent for inhibiting invasiveness of cancer cells |
03/23/2011 | CN101987111A Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
03/23/2011 | CN101987085A High-efficiency adhesive powder for treating livestock and poultry diseases |
03/23/2011 | CN101987083A Preparation method for controlled release preparation, especial for zero-order release controlled release preparation |
03/23/2011 | CN101313873B Biology polypeptide medicament blood vessel bracket and preparation method thereof |
03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
03/22/2011 | US7910626 Use of S1P receptor agonists in heart diseases |
03/22/2011 | US7910594 Antiproliferative agents; gene overexpression |
03/22/2011 | US7910586 Drug screening; administering secretase inhibitor; Alzheimer's disease |
03/22/2011 | US7910580 Antitumor agents, anticancer agents; synergistic mixture; side effect reduction; inhibiting tumor growth in cancer patient by administering a combination therapy comprising 5-Fluorouracil (5-FU) and a methylol transfer agent capable of enhancing antineoplastic effect of 5-FU |
03/22/2011 | US7910562 Method of delivering genes into antigen presenting cells of the skin |
03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
03/22/2011 | US7910139 Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
03/22/2011 | US7910097 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
03/22/2011 | CA2484275C Warming and nonirritating lubricant compositions and method of comparing irritation |
03/22/2011 | CA2480273C Ph-sensitive polymer |
03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
03/22/2011 | CA2471543C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
03/22/2011 | CA2471538C Pyrrolopyrimidines |